Publicaciones en colaboración con investigadores/as de University Hospital of Lausanne (71)

2024

  1. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 6, pp. 752-759

  2. A genome-wide association analysis reveals new pathogenic pathways in gout*

    Nature Genetics

  3. Assessment of bleeding events in patients receiving DOACs with or without statins to treat venous thromboembolism: insights from the RIETE registry

    BMJ open, Vol. 14, Núm. 10, pp. e085401

  4. Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control Study

    Transplantation

  5. Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies

    Schizophrenia Bulletin, Vol. 50, Núm. 4, pp. 771-783

  6. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

    Human Genetics and Genomics Advances, Vol. 5, Núm. 3

  7. PsyCog: A computerised mini battery for assessing cognition in psychosis

    Schizophrenia Research: Cognition, Vol. 37

  8. What is the duration of untreated psychosis worldwide? - A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies

    Psychological Medicine, Vol. 54, Núm. 4, pp. 652-662

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout

    Arthritis and Rheumatology, Vol. 75, Núm. 5, pp. 816-825

  3. Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry (European Journal of Nuclear Medicine and Molecular Imaging, (2023), 50, 7, (1861-1868), 10.1007/s00259-023-06226-z)

    European Journal of Nuclear Medicine and Molecular Imaging

  4. EANM enabling guide: how to improve the accessibility of clinical dosimetry

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 7, pp. 1861-1868

  5. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis

    British Journal of Psychiatry, Vol. 31, Núm. 2

  6. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  7. Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry

    European Journal of Nuclear Medicine and Molecular Imaging

  8. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

    Arthritis and Rheumatology, Vol. 75, Núm. 10, pp. 1703-1713

  9. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 10, pp. 1248-1257

  10. Treatment and long-term outcome in primary nephrogenic diabetes insipidus

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 10, pp. 2120-2130

  11. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823

2022

  1. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

    Annals of Oncology, Vol. 33, Núm. 1, pp. 67-79